Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -256.9% | – | – | – | – | – | – | – | – | – | |
| – | +70.4% | +38.5% | +26.7% | +6.3% | -47.1% | +0.0% | -21.4% | -21.8% | -38.1% | -32.1% | -29.3% | |
| – | +349.6% | -47.2% | -0.5% | -10.8% | -60.9% | +0.0% | -24.3% | -26.6% | -3.1% | -4.2% | +14.7% | |
| – | +32.0% | +24.4% | +15.2% | +50.1% | +34.9% | -68.0% | -75.6% | -7.5% | – | – | – | |
| – | +373.1% | -130.2% | – | – | – | – | – | – | – | -73.5% | +46.5% | |
| – | +100.1% | +148.1% | +47.5% | -10.9% | -81.9% | +0.0% | -3.7% | -32.1% | -68.8% | +458.9% | -76.8% | |
| – | +902.0% | -89.1% | – | -244.9% | – | +0.0% | -368.3% | – | -101.4% | +571.0% | -92.6% | |
| – | – | – | -81.6% | – | – | – | – | – | – | – | – | |
| – | – | -100.2% | +0.0% | – | -86.6% | +11,119.5% | -98.3% | -99.8% | -100.0% | – | – | |
| – | +43.3% | -87.6% | +97.7% | – | -99.4% | -298.7% | -80.7% | +33,224.7% | -72.2% | -100.0% | – | |
| – | +1,288.3% | -96.4% | -64.5% | +7,131.4% | -89.4% | +0.0% | +270.5% | -228.1% | – | +273.7% | -18.6% | |
| – | – | -167.6% | – | +529.3% | -146.7% | – | – | – | -875.7% | – | -96.7% | |
| – | – | -482.2% | – | – | – | – | – | – | – | – | – |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.